Drug Development for Opportunistic Infections - Mycobacterium Avium

Abstract

Perform efficacy evaluations of candidate therapeutic agents against MYCOBACTERIUM AVIUM in a standardized, validated mouse model test system. Identify and obtain candidate therapeutic agents for efficacy evaluations against MYCOBACTERIUM AVIUM.

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research and Development Contracts (N01)
Project #: N01AI25468-8-0-1
Application #: 7648979
Study Section

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year: 2008
Total Cost: $867,678
Indirect Cost

Institution

Name: California Pacific Medical Center Research Institute
Department
Type
DUNS #: 071882724

City: San Francisco
State: CA
Country: United States
Zip Code: 94107

Related projects


NIH 2008 N01 AI	Drug Development for Opportunistic Infections - Mycobacterium Avium / California Pacific Medical Center Research Institute	$867,678
NIH 2007 N01 AI	Drug Development for Opportunistic Infections - Mycobaterium Young, Lowell S. /	$697,182
NIH 2007 N01 AI	Drug Development for Opportunistic Infections - Mycobacterium Avium /	$697,182

Comments

Be the first to comment on this grant